Page last updated: 2024-11-07

loe 908

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

LOE 908: inhibitor of receptor-activated nonselective cation currents in HL-60 cells; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID122081
CHEMBL ID1557889
CHEMBL ID2356116
SCHEMBL ID1921120
MeSH IDM0217039

Synonyms (28)

Synonym
NCGC00161399-01
loe 908
(+-)-3,4-dihydro-6,7-dimethoxy-alpha-phenyl-n,n-bis(2,3,4-trimethoxyphenethyl)-1-isoquinolineacetamide
1-isoquinolineacetamide, 3,4-dihydro-6,7-dimethoxy-alpha-phenyl-n,n-bis(2-(2,3,4-trimethoxyphenyl)ethyl)-, (+-)-
(3,4-dihydro-6,7-dimethoxyisoquinoline-1-gamma-1)-2-phenyl-n,n-di(2-(2,3,4-trimethoxyphenyl)ethyl)acetamide
loe-908
2-(6,7-dimethoxy-3,4-dihydroisoquinolin-1-yl)-2-phenyl-n,n-bis[2-(2,3,4-trimethoxyphenyl)ethyl]acetamide
NCGC00161399-02
CHEMBL1557889
unii-7j9zz971ao
149759-26-2
7j9zz971ao ,
pinokalant
pinokalant [inn]
(+/-)-3,4-dihydro-6,7-dimethoxy-.alpha.-phenyl-n,n-bis(2,3,4-trimethoxyphenethyl)-1-isoquinolineacetamide
143482-63-7
1-isoquinolineacetamide, 3,4-dihydro-6,7-dimethoxy-.alpha.-phenyl-n,n-bis(2-(2,3,4-trimethoxyphenyl)ethyl)-, (+/-)-
SCHEMBL1921120
DTXSID7048401
CHEMBL2356116 ,
bdbm50103612
(r,s)-(3,4-dihydro-6,7-dimethoxy-isoquinoline-1-yl)-2-phenyl-n,n-di-[2-(2,3,4-trimethoxyphenyl)ethyl]-acetamide
2-(6,7-dimethoxy-3,4-dihydroisoquinolin-1-yl)-2-phenyl-n,n-bis(2,3,4-trimethoxyphenethyl)acetamide
BRD-A33676200-003-01-7
Q27268408
BCP16816
loe-908;loe908;loe 908
HY-124304

Research Excerpts

Overview

LOE 908 is a blocker of NSCC-1 andNSCC-2, whereas SK&F 96365 is an inhibitor for NS CC-2. LOE 908 is a blocker for NSCCs 1 and 2, whereasSK&F 96365 is an inhibitor of SOCC and NSCC.

ExcerptReferenceRelevance
"LOE 908 is a blocker of NSCC-1 and NSCC-2, whereas SK&F 96365 is a blocker of SOCC and NSCC-2."( Effects of phosphoinositide 3-kinase on the endothelin-1-induced activation of voltage-independent Ca(2+) channels and mitogenesis in Chinese hamster ovary cells stably expressing endothelin(a) receptor.
Hashimoto, N; Kawanabe, Y; Masaki, T, 2002
)
1.04
"LOE 908 is a blocker of NSCC-1 and NSCC-2, whereas SK&F 96365 is a blocker of NSCC-2."( Role of phosphoinositide 3-kinase in the nonselective cation channel activation by endothelin-1/endothelinB receptor.
Hashimoto, N; Kawanabe, Y; Masaki, T, 2003
)
1.04
"LOE 908 is a blocker for NSCC-1 and NSCC-2, whereas SK&F 96365 is an inhibitor for NSCC-2."( Molecular mechanisms for the activation of Ca2+-permeable nonselective cation channels by endothelin-1 in C6 glioma cells.
Hashimoto, N; Kawanabe, Y; Masaki, T, 2003
)
1.04
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (9)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, TYROSYL-DNA PHOSPHODIESTERASEHomo sapiens (human)Potency56.23410.004023.8416100.0000AID485290
Chain A, Putative fructose-1,6-bisphosphate aldolaseGiardia intestinalisPotency15.81140.140911.194039.8107AID2451
Chain A, CruzipainTrypanosoma cruziPotency39.81070.002014.677939.8107AID1476
USP1 protein, partialHomo sapiens (human)Potency56.23410.031637.5844354.8130AID504865
TDP1 proteinHomo sapiens (human)Potency6.86600.000811.382244.6684AID686978; AID686979
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency39.81070.011212.4002100.0000AID1030
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency22.38720.035520.977089.1251AID504332
DNA polymerase kappa isoform 1Homo sapiens (human)Potency19.95260.031622.3146100.0000AID588579
peripheral myelin protein 22Rattus norvegicus (Norway rat)Potency28.69540.005612.367736.1254AID624032
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (50)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's14 (28.00)18.2507
2000's30 (60.00)29.6817
2010's6 (12.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.38

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.38 (24.57)
Research Supply Index3.93 (2.92)
Research Growth Index4.31 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.38)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (6.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other47 (94.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]